Pam Murphy | IR Consultant |
Bill Collier | President & CEO |
David Hastings | CFO |
Gaston Picchio | CDO |
Michael Sofia | CSO |
Neil Panchal | JMP Securities |
Keay Nakae | Chardan |
Ladies and gentlemen, thank you for standing by and welcome to the Arbutus Biopharma Corporation 2019 Third Quarter Financial Results and Corporate Update. At this time, all lines are being placed on mute. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded.